CRM vs ORCL
CRM and ORCL side by side — valuation & fundamentals (public data).
Key statistics
| Metric | CRMSalesforce, Inc. | ORCLOracle Corporation |
|---|---|---|
| Market cap | $139.90B | $363.11B |
| P/E (TTM) | 19.8 | 21.6 |
| P/B | 4.09 | 8.54 |
| P/S | 3.4x | 5.4x |
| Dividend yield | — | 1.59% |
| Revenue | $42.83B(TTM) | $67.36B(TTM) |
| Revenue growth (YoY) | 9.6% | 17.3% |
| Net income | $8.02B(TTM) | $17.09B(TTM) |
| Earnings growth (YoY) | 20.3% | 37.3% |
| EPS, diluted | $8.63(TTM) | $5.83(TTM) |
| EBIT margin | 20.1% | 30.6% |
| ROE | 21.8% | 40.2% |
| ROIC | 10.1% | 90.5% |
| Piotroski F | 7/9 | — |
| 1y total return | -33.5% | -48.5% |
Figures from SEC filings · for reference only · not investment advice
Crecimiento de $10,000: CRM frente a ORCL
| Métrica | CRM | ORCL |
|---|---|---|
| Valor final | $24.2K | $38.2K |
| Retorno total | +142.3% | +281.7% |
| CAGR | +8.9% | +13.8% |
| Volatilidad | 35.1% | 35.0% |
| Sharpe | 0.31 | 0.43 |
| Sortino | 0.44 | 0.67 |
| Caída máxima | -58.7% | -61.7% |
Basado en 2600 días de negociación comunes, 2016-03-15 → 2026-07-17 · tasa libre de riesgo 3.85% (bono corto del Tesoro actual, mantenido constante)
A head-to-head total-return backtest over real split- and dividend-adjusted prices: how a one-time $10,000 investment in each stock, held to today, would have grown over their common window — including reinvested dividends. A disclosed historical statistic — NOT a prediction, a guarantee, or investment advice. Past performance does not predict future results.
Related comparisons
Delayed data · Public sources · For reference only · Not investment advice (this page declares no winner)